Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effectiveness, safety, and immunogenicity of half dose ChAdOx1 nCoV-19 COVID-19 Vaccine: Viana project.
Valim V, Martins-Filho OA, Gouvea MDPG, Camacho LAB, Villela DAM, de Lima SMB, Azevedo AS, Neto LFP, Domingues CMAS, de Medeiros Junior NF, Moulaz IR, Dias LH, Miyamoto ST, Teixeira-Carvalho A, Mill JG; Half Dose ChAdOx Study Group. Valim V, et al. Among authors: moulaz ir. Front Immunol. 2022 Aug 29;13:966416. doi: 10.3389/fimmu.2022.966416. eCollection 2022. Front Immunol. 2022. PMID: 36105814 Free PMC article. Clinical Trial.
Antisynthetase Syndrome after chikungunya infection: A case report.
Tuão RC, Macabú MO, Athayde PDS, Moulaz IR, Dalmaso BF, Cristo VV, Machado KLLL. Tuão RC, et al. Among authors: moulaz ir. Clin Case Rep. 2022 Sep 12;10(9):e05877. doi: 10.1002/ccr3.5877. eCollection 2022 Sep. Clin Case Rep. 2022. PMID: 36172330 Free PMC article.
Giant lactating adenoma.
Moulaz IR, de Oliveira FSS, da Silva EC, Machado JM, Santos MCLFS. Moulaz IR, et al. Autops Case Rep. 2021 Apr 15;11:e2021252. doi: 10.4322/acr.2021.252. Autops Case Rep. 2021. PMID: 33968827 Free PMC article.
Anti-SARS-CoV-2 antibody immunoreactivity profiles during COVID-19 recurrence.
Gouvea MDPG, Moulaz IR, Gouveia TM, Lança KEM, Lacerda BSP, Thompson BP, Polese J, Lima MD, Ribeiro-Rodrigues R, Mill JG, Valim V. Gouvea MDPG, et al. Among authors: moulaz ir. Rev Soc Bras Med Trop. 2022 Oct 24;55:e01062022. doi: 10.1590/0037-8682-0106-2022. eCollection 2022. Rev Soc Bras Med Trop. 2022. PMID: 36287469 Free PMC article.
Timeline kinetics of protective immunity to SARS-CoV-2 upon primary vaccination and humoral response to variants after booster dose.
da Penha Gomes Gouvea M, Lira Machado KLL, de Oliveira YGP, Moulaz IR, Henriques AG, Gouveia TM, Thompson BP, Lança KEM, de Souza Ramos S, Lacerda GCC, Lenzi JPG, de Castro Pimentel F, Miossi JPM, Rassele ML, Camacho LAB, Villela DAM, de Lima SMB, de Souza Azevedo A, Horbach IS, de Araújo MF, Tort LFL, de Oliveira ACA, Siqueira MM, Garcia CC, da Costa-Rocha IA, Campi-Azevedo AC, Peruhype-Magalhães V, da Silva VG, Miyamoto ST, Dos Santos Fantoni RN, Pinto-Neto LF, Magda Domingues C, de Medeiros Junior NF, Burian AP, Teixeira-Carvalho A, Mota LMH, Mill JG, Martins-Filho OA, Valim V. da Penha Gomes Gouvea M, et al. Among authors: moulaz ir. Vaccine. 2023 Oct 20;41(44):6514-6528. doi: 10.1016/j.vaccine.2023.08.022. Epub 2023 Sep 1. Vaccine. 2023. PMID: 37661534
Immunogenicity and Safety According to Immunosuppressive Drugs and Different COVID-19 Vaccine Platforms in Immune-Mediated Disease: Data from SAFER Cohort.
Machado KLLL, Burian APN, Martins-Filho OA, Mill JG, Ferreira LB, Tapia KRL, Moulin ACS, Moulaz IR, Ribeiro PDC, Magalhães VO, Biegelmeyer E, Peixoto FMMMC, Ribeiro SLE, Telles CMPF, Bühring J, Sartorio NS, Hax V, Rezende RPV, Baptista KL, Melo AKG, Cruz VA, Vieira RMRA, Azevedo RH, Azevedo VF, Pinheiro MM, Monticielo OA, Reis Neto ETD, Teixeira-Carvalho A, Xavier RM, Sato EI, de Souza VA, Ferreira GA, Pileggi GS, Valim V. Machado KLLL, et al. Among authors: moulaz ir. Vaccines (Basel). 2024 Dec 3;12(12):1367. doi: 10.3390/vaccines12121367. Vaccines (Basel). 2024. PMID: 39772029 Free PMC article.
15 results